CIBC Bancorp USA »

BioMarin Pharmaceutical shares owned by CIBC Bancorp USA

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by CIBC Bancorp USA from 13F filings

Historical chart of CIBC Bancorp USA investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by CIBC Bancorp USA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by CIBC Bancorp USA

Quarter filed Position value Share count Share price at filing
2026-03-31 $12M 208k 56.49
2025-09-30 $372k 6.9k 54.16

More positions owned by CIBC Bancorp USA

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
Astrazeneca Ord (AZN)
Eli Lilly & Co. (LLY)
Flutter Entmt SHS (FLUT)
Vanguard Index Fds Mid Cap Etf (VO)
Exxon Mobil Corporation (XOM)

View all positions for CIBC Bancorp USA

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
Dodge & Cox
PRIMECAP Management Company
Vanguard Capital Management
Vanguard Portfolio Management
AQR Capital Management
State Street Corporation
Viking Global Investors
Citadel Advisors
Geode Capital Management
Dimensional Fund Advisors
Vestal Point Capital
Capital Research Global Investors
Millennium Management

View all funds holding BioMarin Pharmaceutical